Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfeiffer and Valois, members of Aptargroup, a family of companies in the consumer dispensing and drug delivery systems industry, have reformed their pharmaceutical businesses under a common brand named Aptar Pharma.
Subscribe to our email newsletter
Aptar Pharma organisation is expected to be implemented progressively during 2010, and will be fully operational in the beginning of 2011.
Pfeiffer and Valois said that the new organisation will be providing patient-friendly drug delivery solutions and will work to satisfy customer needs.
Aptar Pharma will have two divisions: Consumer Health Care, focused on drug delivery solutions adapted to over-the-counter medications; and Prescription, focused on drug delivery solutions specific to physician-prescribed medicines.
Approximately 6% of Aptar Pharma’s annual turnover is dedicated to research, development and industrialisation of novel products.
Aptar Pharma R&D and marketing staff will work closer together in a global market-focused team of 200 people dedicated to satisfying customer needs.
Peter Pfeiffer, president and CEO of Aptargroup, said: “We have always been driven to better serve our customers by enhancing our understanding of their needs and the changing markets in which they operate.
“This realignment will make it even easier for customers to do business with us, and we will be able to offer our full product range in each of our three segments. This next strategic step will put us in position to continue our long-term growth and lead our industry for many years to come.”